Methotrexate

Kevin D. Pile; Garry G. Graham

doi:10.1007/978-3-7643-8550-7_47

Methotrexate

Kevin D. Pile, Garry G. Graham

Research output: Chapter in Book / Conference Paper › Chapter

5 Citations (Scopus)

Abstract

Methotrexate is an analogue of folates (Fig. 1) and is a cytotoxic drug used in the treatment of several malignancies. At low doses, methotrexate is a member of the drug group slow-acting antirheumatic drugs (SAARDs). Methotrexate is also a member of a group of drugs known as conventional synthetic disease-modifying antirheumatic drugs (csDMARDs).

Original language	English
Title of host publication	Compendium of Inflammatory Diseases
Editors	Michael J. Parnham
Place of Publication	Switzerland
Publisher	Springer
Pages	934-942
Number of pages	9
ISBN (Electronic)	9783764385507
ISBN (Print)	9783764385309
DOIs	https://doi.org/10.1007/978-3-7643-8550-7_47
Publication status	Published - 2016

Keywords

antirheumatic agents
methotrexate

Access to Document

10.1007/978-3-7643-8550-7_47

Cite this

@inbook{670b9ad54dae4694aa5c6383fa05b1ea,

title = "Methotrexate",

abstract = "Methotrexate is an analogue of folates (Fig. 1) and is a cytotoxic drug used in the treatment of several malignancies. At low doses, methotrexate is a member of the drug group slow-acting antirheumatic drugs (SAARDs). Methotrexate is also a member of a group of drugs known as conventional synthetic disease-modifying antirheumatic drugs (csDMARDs).",

keywords = "antirheumatic agents, methotrexate",

author = "Pile, {Kevin D.} and Graham, {Garry G.}",

year = "2016",

doi = "10.1007/978-3-7643-8550-7_47",

language = "English",

isbn = "9783764385309",

pages = "934--942",

editor = "Parnham, {Michael J.}",

booktitle = "Compendium of Inflammatory Diseases",

publisher = "Springer",

}

TY - CHAP

T1 - Methotrexate

AU - Pile, Kevin D.

AU - Graham, Garry G.

PY - 2016

Y1 - 2016

N2 - Methotrexate is an analogue of folates (Fig. 1) and is a cytotoxic drug used in the treatment of several malignancies. At low doses, methotrexate is a member of the drug group slow-acting antirheumatic drugs (SAARDs). Methotrexate is also a member of a group of drugs known as conventional synthetic disease-modifying antirheumatic drugs (csDMARDs).

AB - Methotrexate is an analogue of folates (Fig. 1) and is a cytotoxic drug used in the treatment of several malignancies. At low doses, methotrexate is a member of the drug group slow-acting antirheumatic drugs (SAARDs). Methotrexate is also a member of a group of drugs known as conventional synthetic disease-modifying antirheumatic drugs (csDMARDs).

KW - antirheumatic agents

KW - methotrexate

UR - http://handle.westernsydney.edu.au:8081/1959.7/uws:40022

U2 - 10.1007/978-3-7643-8550-7_47

DO - 10.1007/978-3-7643-8550-7_47

M3 - Chapter

SN - 9783764385309

SP - 934

EP - 942

BT - Compendium of Inflammatory Diseases

A2 - Parnham, Michael J.

PB - Springer

CY - Switzerland

ER -

Methotrexate

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this